Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Roth

Showing results (731-740 of 940) with videos related to

Pageof 94
Sort By:
Bioorganic & Medicinal Chemistry Letters|January 1, 1999
Inhibitors of acyl-CoA:cholesterol O-acyltransferase (ACAT) as hypocholesterolemic agents: synthesis and structure-activity relationships of novel series of sulfonamides, acylphosphonamides and acylphosphoramidatesH T Lee, W H Roark, J A Picard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 5, 2004
Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancerL Rubbia-Brandt, V Audard, P Sartoretti, et al.
Cancer Gene Therapy|January 1, 1997
A comparison of gene transfer methods in human dendritic cellsJ F Arthur, L H Butterfield, M D Roth, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 20, 2018
Efficacy and Safety of Subcutaneous Belimumab in Anti-Double-Stranded DNA-Positive, Hypocomplementemic Patients With Systemic Lupus ErythematosusA Doria, W Stohl, A Schwarting, et al.
Journal of Medicinal Chemistry|October 1, 1993
Inhibitors of acyl-CoA:cholesterol acyltransferase. 5. Identification and structure-activity relationships of novel beta-ketoamides as hypocholesterolemic agentsC E Augelli-Szafran, C J Blankley, B D Roth, et al.
Human Gene Therapy|March 10, 2009
Protein scaffold and expression level determine antiviral activity of membrane-anchored antiviral peptidesFelix G Hermann, Holger Martinius, Marc Egelhofer, et al.
Diagnostic Cytopathology|July 12, 2002
Rare atypical squamous cells of undetermined significance (ASCUS): a clinically significant diagnosis?H Daniel Hoerl, Michelle D Roth-Cline, John E Shalkham, et al.
Transplantation|May 15, 2001
Six-year clinical effect of donor bone marrow infusions in renal transplant patientsG Ciancio, J Miller, R O Garcia-Morales, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|November 1, 1994
Effects of recombinant human erythropoietin on renal function in chronic renal failure predialysis patientsD Roth, R D Smith, G Schulman, et al.
The Lancet. Rheumatology|September 25, 2023
Sex differences in clinical outcomes and biological profiles in systemic sclerosis-associated interstitial lung disease: a post-hoc analysis of two randomised controlled trialsElizabeth R Volkmann, Donald P Tashkin, Richard Silver, et al.
Pageof 94

Showing results (731-740 of 940) with videos related to

Sort By:
Pageof 94
Bioorganic & Medicinal Chemistry Letters|January 1, 1999
Inhibitors of acyl-CoA:cholesterol O-acyltransferase (ACAT) as hypocholesterolemic agents: synthesis and structure-activity relationships of novel series of sulfonamides, acylphosphonamides and acylphosphoramidatesH T Lee, W H Roark, J A Picard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 5, 2004
Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancerL Rubbia-Brandt, V Audard, P Sartoretti, et al.
Cancer Gene Therapy|January 1, 1997
A comparison of gene transfer methods in human dendritic cellsJ F Arthur, L H Butterfield, M D Roth, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 20, 2018
Efficacy and Safety of Subcutaneous Belimumab in Anti-Double-Stranded DNA-Positive, Hypocomplementemic Patients With Systemic Lupus ErythematosusA Doria, W Stohl, A Schwarting, et al.
Journal of Medicinal Chemistry|October 1, 1993
Inhibitors of acyl-CoA:cholesterol acyltransferase. 5. Identification and structure-activity relationships of novel beta-ketoamides as hypocholesterolemic agentsC E Augelli-Szafran, C J Blankley, B D Roth, et al.
Human Gene Therapy|March 10, 2009
Protein scaffold and expression level determine antiviral activity of membrane-anchored antiviral peptidesFelix G Hermann, Holger Martinius, Marc Egelhofer, et al.
Diagnostic Cytopathology|July 12, 2002
Rare atypical squamous cells of undetermined significance (ASCUS): a clinically significant diagnosis?H Daniel Hoerl, Michelle D Roth-Cline, John E Shalkham, et al.
Transplantation|May 15, 2001
Six-year clinical effect of donor bone marrow infusions in renal transplant patientsG Ciancio, J Miller, R O Garcia-Morales, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|November 1, 1994
Effects of recombinant human erythropoietin on renal function in chronic renal failure predialysis patientsD Roth, R D Smith, G Schulman, et al.
The Lancet. Rheumatology|September 25, 2023
Sex differences in clinical outcomes and biological profiles in systemic sclerosis-associated interstitial lung disease: a post-hoc analysis of two randomised controlled trialsElizabeth R Volkmann, Donald P Tashkin, Richard Silver, et al.
Pageof 94